CELC
CELC
NASDAQ · Biotechnology

Celcuity Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$110.22
+8.21 (+8.05%)
As of Mar 25, 9:54 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target -76.8% upside
Low Target $16.07
Average Target $25.56
High Target $38.64
Current Price $110.22
Current
$110.22
Target
$25.56
$16.07 $25.56 avg $38.64
Scenario Analysis
Bear Case
$16.07
-85.4%
Low target
Base Case
$25.56
-76.8%
Avg target
Bull Case
$38.64
+-64.9%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$120.32
-8.4% from high
52-Week Low
$7.58
+1,355.0% from low
50-Day SMA
$105.59
+4.4% vs SMA
200-Day SMA
$59.11
+86.5% vs SMA
RSI (14)
39.6
Neutral
Target vs 52W High
$25.56
-78.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%